| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |